Tech Company Financing Transactions
BCD Bioscience Funding Round
Acre Venture Partners, Collaborative Fund and iSelect invested in a $12 million Series A funding round for BCD Bioscience. The round was recorded on 4/15/2022.
Transaction Overview
Company Name
Announced On
4/15/2022
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to obtain regulatory approvals for lead products, upscale production capabilities, expand the product pipeline, and to continue to build out the prediction and screening platform.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
231 G St. 24
Davis, CA 95616
USA
Davis, CA 95616
USA
Phone
Undisclosed
Website
Email Address
Overview
BCD Bioscience is creating the world's first broad library of oligosaccharides with diverse natural structures, and linking these structures to their functions as prebiotics and immunomodulators. We are using our technology to develop ingredients and therapies for better human and animal health both alone and in partnership with others.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steve Watkins
VP - Bus. Development
Bruce McConnell
VP - Product Management
Angela Marcobal
VP - R & D
Matthew Amicucci
Browse more venture capital transactions:
Prev: 4/15/2022: Elastics.cloud venture capital transaction
Next: 4/15/2022: Rapido venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to record tech company VC transactions. VC investment data records reported here come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs